IGF1 and Cirrhosis: Recent studies from our laboratory in rats with carbon tetrachloride-induced cirrhosis have demonstrated that short courses of treatment with low doses of IGF-I are able to produce systemic beneficial effects [6-13] and are associated to hepatoprotective [14,15] and antifibrogenic [16] effects.